| Business Type | Exporter, Supplier, Retailer |
| Size | 76 mg/1.9 mL |
| Type | Oncology biologic immunotherapy |
| Material | Elranatamab‑bcmm bispecific antibody |
| Click to view more | |
Product Details
Brand Name
ELREXFIO
Color
Colorless
Form
injection
Usage
Hospital
Country of Origin
USA
Port
California
Payment Terms
T/T, Western Union, Other
Delivery Time
3 days
Packaging Details
ELREXFIO (elranatamab‑bcmm) is a bispecific antibody biologic used to treat adults with relapsed or refractory multiple myeloma after multiple prior therapies. It is given as a subcutaneous solution in ready‑to‑use vials and is approved for use under stringent safety monitoring due to immune activation effects.
ELREXFIO (elranatamab‑bcmm) is a bispecific antibody biologic used to treat adults with relapsed or refractory multiple myeloma after multiple prior therapies. It is given as a subcutaneous solution in ready‑to‑use vials and is approved for use under stringent safety monitoring due to immune activation effects.
Looking for "Elrexfio Elranatamab-bcmm Injection" ?
box
